Skip to main content
. 2019 Apr;39(2):103–106. doi: 10.14639/0392-100X-1796

Table I.

Baseline characteristics of the study population.

RLS No RLS P values
No. of patients 20 20
Age (mean ± SD) 33 ± 8.23 45.20 ± 7.05 0.007
Gender (M/F) 12/8 8/12 0.579
Side (right/left) 16/4 0/20 0.009
Pre-treatment PTA (dB) 74 ± 10.84 74 ± 28.81 1
Vertigo (%) 80 20 0.07
Comorbidities (%)
    arterial hypertension 20 80 0.07
    hyperglycaemia 20 60 0.24
    hypercholesterolemia 0 80 0.004
    dysthyroidism 0 0 1